⟵ Back to Search Results

BGB-290-104

Completed

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

Beigene Study ID info

BGB-290-104

ClinicalTrials.gov ID info

NCT03150862

EudraCT Number info

2017-001554-33

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

Study Documents

Study Protocol Statistical Analysis Plan